Cellix Bio Private Limited - pharma in Hyderabad, Telangana, India. FY 2026 financials & compliance.
CIN U74900TG2014PTC094095 Incorporated 21 May 2014 ROC Hyderabad HQ Hyderabad, Telangana, India
Active Private Limited Company pharma MSME · Micro
Revenue · FY 2024
₹61,900
▼ 71% YoY
Net loss · FY 2024
₹58.52 Lakh
Latest filing
EBITDA · FY 2024
-₹8.72 Lakh
Latest filing
Authorised capital
₹23.1 Cr
Registered with MCA
Paid-up capital
₹22.47 Cr
Issued & subscribed
Company age
12 yrs
Est. 2014
Directors on board
4
As per MCA filings
Active GSTINs
1
GST registered

About Cellix Bio Private Limited

Data last updated:

Cellix Bio Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 21 May 2014 and has been in existence for over 12 years.

The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U74900TG2014PTC094095. Its GSTIN is 36AAFCC6648A1ZU (Telangana).

The company has an authorised share capital of ₹23.1 Cr and a paid-up capital of ₹22.47 Cr. It is led by directors including Achanna Chowdary Valluri and Mahesh Kandula.

Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Hyderabad, Telangana.

As per the financials filed for FY 2024, the company reported a revenue of ₹61,900, a decline of 71% compared to the previous year. For the same year it recorded a net loss of ₹58.52 Lakh and EBITDA of -₹8.72 Lakh. Revenue has declined at a compounded annual rate (CAGR) of 61% over three years and 75% over five years.

Its group structure includes 2 subsidiaries.

The company is associated with 2 brands: Cellix Bio Pharma and Cellix Bio. Court records list 12 cases involving the company, including 5 filed by the company and 7 filed against it; 6 cases are pending. The company has 10 deals on record (6 funding rounds, 2 rights issues, 2 secondary share transfers), with disclosed funding of ₹36.49 Cr; the latest was in August 2020. Its 10 peer companies in the Pharma industry (Formulations) are compared by revenue, 5 larger and 5 smaller; the largest is Eureka Aventis Labs Limited with revenue of ₹65,000.

Cellix Bio Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-TS-02-0049734). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website cellixbio.com.

Company details

CIN U74900TG2014PTC094095
Registration Number 094095
Incorporation Date 21 May 2014
ROC Hyderabad
Listing Status Unlisted
Company Status Active
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-TS-02-0049734

CIN history

Cellix Bio has one previous CIN (Corporate Identification Number): U74900AP2014PTC094095. The current CIN is U74900TG2014PTC094095, which is the unique identifier assigned by the Registrar of Companies.

CINStatus
U74900TG2014PTC094095Current
U74900AP2014PTC094095Previous

Recognitions & Rankings of Cellix Bio

MSME (Udyam registered) Ministry of MSME
Category
Micro (2023-24)
Udyam number
UDYAM-TS-02-0049734

Contact details

Cellix Bio Private Limited's registered office is in Hyderabad, Telangana. Its website is cellixbio.com. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Registered Address
    Bc – 08 Ground Floor Block B Indu Fortune Annexe, Phase 13 Kukatpally, Hyderabad, Telangana, India – 500085
  • Industry
    Pharma, Drug Formulation & Development

To see the full contact details of Cellix Bio Private Limited, buy the company report.

Comprehensive company report
Cellix Bio Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Brands

Cellix Bio operates two associated brands: Cellix Bio Pharma and Cellix Bio. Each brand links to its own profile.

BrandDescriptionWebsite
A CDMO specializing in the manufacturing of solid drug formulations.cellixbiopharma.com
Drug discovery is accelerated by AI platform for diseases.cellixbio.com

Financials of Cellix Bio Private Limited

FY 2024 filings available

Cellix Bio Private Limited reported revenue of ₹61,900 (down 71% YoY) for FY 2024.

Revenue · FY 2024
₹61,900 ▼ 71%
Net loss · FY 2024
₹58.52 Lakh
EBITDA · FY 2024
-₹8.72 Lakh

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▼ 71%
3 years · compounded
▼ 61%
5 years · compounded
▼ 75%
EBITDA CAGR growth
1 year
▲ 72%
3 years · compounded
▲ 38%
5 years · compounded
▼ 16%

Revenue has declined at a compounded annual rate (CAGR) of 75% over five years, including a 71% fall in the latest year. EBITDA rose 72% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA-₹8.72 Lakh
Profit Before Tax
Tax Expense
Net Profit (PAT)-₹58.52 Lakh
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Profitability
EBITDA Margin
Net Profit Margin
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Cellix Bio Private Limited, buy the company report.

Board of directors of Cellix Bio Private Limited

Cellix Bio has 4 current directors and 10 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Achanna Chowdary ValluriDirector21 May 201412 Years 6 MonthsCurrent
Mahesh KandulaDirector01 Oct 201412 Years 1 MonthsCurrent
Subramaniam ApparsundaramDirector06 Oct 20179 Years 1 MonthsCurrent
Sridhar KogantiDirector27 Dec 20232 Years 10 MonthsCurrent

Peer comparison

Cellix Bio Private Limited is compared with the 10 companies closest to it by revenue in the Pharma industry (Formulations), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Eureka Aventis Labs Limited₹65,000 (FY 2025)Delhi, India
Aci Pharma Private Limited₹64,244 (FY 2024)-94.0%New Delhi, Delhi, India
R P Wires & Cables Private Limited₹63,127 (FY 2025)-100.0%Lucknow, Uttar Pradesh, India
Pushkar Pharmaceuticals Pvt Ltd₹63,000 (FY 2024)23.0%Chandigarh, India
Emsons Pharmaceuticals Pvt Ltd₹62,450 (FY 2020)13.0%Kolkata, West Bengal, India
Cellix Bio Private Limitedthis company₹61,900 (FY 2024)-₹58.52 Lakh-71.0%Hyderabad, Telangana, India
Avaca Pharma Private Limited₹61,895 (FY 2024)49.0%Guntur, Andhra Pradesh, India
Adney Formulations Private Limited₹61,000 (FY 2023)455.0%Vasai, Maharashtra, India
Pharmetro Life Sciences Private Limited₹60,824 (FY 2024)17.0%Lucknow, Uttar Pradesh, India
Nirmaya Laboratories Private Limited₹60,199 (FY 2025)Vadodara, Gujarat, India
Modern Fastners Pvt Ltd₹60,000 (FY 2025)Chandigarh, India

To see the full peer comparison of Cellix Bio Private Limited, buy the company report.

Shareholding

The shareholding of Cellix Bio Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2023FY 2022FY 2021FY 2020FY 2019
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Cellix Bio Private Limited, buy the company report.

Deals & funding

Cellix Bio Private Limited has 10 deals on record (6 funding rounds, 2 rights issues, 2 secondary share transfers), with disclosed funding of ₹36.49 Cr; the latest was in August 2020.

Total deals
10
Funding rounds
6
Rights issues
2
Secondary share transfers
2
Disclosed funding
₹36.49 Cr

Deals on record (5 of 10)

WhenDealAmountParties
Aug 2020Funding round₹3.7 CrInvestors: Total Clarity Inc
Dec 2019Funding round₹7.51 CrInvestors: 2 individuals
Feb 2019Funding round₹11.02 CrInvestors: 3 individuals
Oct 2018Funding round₹3.51 CrInvestors: an individual
Jul 2018Rights issue₹1.7 CrInvestors: an individual

To see the full deal history of Cellix Bio Private Limited, buy the company report.

Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.

MSME payment delays

No delayed payments to MSME suppliers are on our record for Cellix Bio Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

Group structure & subsidiaries

Cellix Bio has 2 subsidiary companies. This group structure data is as of FY 2023. The table lists each entity with its relationship and holding.

2
Subsidiary companies
Key subsidiaries
Company NameCINShares held
Cellix Bio Pharma Private LimitedU73100TG2020PTC138576
Avaca Pharma Private LimitedU74999AP2016PTC104239

To see the full group structure of Cellix Bio Private Limited, buy the company report.

GST

Cellix Bio has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
36AAFCC6648A1ZUTelanganaActive26 Jul 2017

To see the full GST registrations and return filing status of Cellix Bio Private Limited, buy the company report.

Recent activity

Cellix Bio Private Limited has 10 board changes on record since 2014: 4 appointments and 6 cessations. The latest: Nagendra Naidu Nutanapati ceased to be Company Secretary on 31 May 2024.

AGM
Cellix Bio Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Ceased
Nagendra Naidu Nutanapati ceased to be Company Secretary.
Filing
Cellix Bio Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Hyderabad.
Appointed
Sridhar Koganti was appointed as Director.
Ceased
Sridhar Koganti ceased to be Additional Director.
Ceased
Apparsundram Rajanikanth ceased to be Additional Director.
Ceased
Mahesh Kandula ceased to be Whole-Time Director.
Ceased
Veera Venkata Rama Rao Remella ceased to be Whole-Time Director.
Ceased
Partha Sarathy Bhagavathula ceased to be Director.
Appointed
Subramaniam Apparsundaram was appointed as Director.
Appointed
Mahesh Kandula was appointed as Director.
Appointed
Achanna Chowdary Valluri was appointed as Director.

1 earlier event is in the company report.

Frequently asked questions

Cellix Bio is an active private limited company based in Hyderabad, Telangana, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 21 May 2014 (12+ years old) and is registered under CIN U74900TG2014PTC094095.

Cellix Bio has 4 current directors:

The latest financial statements of Cellix Bio on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.

The GSTIN of Cellix Bio is 36AAFCC6648A1ZU, registered in Telangana.

The CIN (Corporate Identification Number) of Cellix Bio is U74900TG2014PTC094095. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Cellix Bio has 12 court cases on record: 5 filed by the company and 7 filed against it. 6 are pending. Most are in the high courts.

Cellix Bio was incorporated on 21 May 2014, making it 12+ years old. It is registered with the Registrar of Companies, Hyderabad.

Cellix Bio has 10 deals on record (6 funding rounds, 2 rights issues, 2 secondary share transfers), with disclosed funding of ₹36.49 Cr; the latest was in August 2020.

The peers of Cellix Bio by revenue are Eureka Aventis Labs Limited, Aci Pharma Private Limited, R P Wires & Cables Private Limited, Pushkar Pharmaceuticals Pvt Ltd, Emsons Pharmaceuticals Pvt Ltd and 5 more, all in the Pharma industry (Formulations).

Nagendra Naidu Nutanapati ceased to be Company Secretary on 31 May 2024. Sridhar Koganti was appointed as Director on 27 Dec 2023. Sridhar Koganti ceased to be Additional Director on 06 Dec 2023. Cellix Bio has 10 board changes on record in total.

Yes, Cellix Bio is registered as a micro enterprise under Udyam registration (number: UDYAM-TS-02-0049734).